Due Process Continuity of Care Act

Public Law 117-328, Consolidated Appropriations Act, FY2023, Mental Health and Recovery Services H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Mental Health and Recovery Services; Monitor Integrated Health Services Medicaid Inmate Exclusion related issues, as follows: H.R.955/S.285, Medicaid Reentry Act of 2021 H.R.6636/S.2697, Due Process Continuity of Care Act S.3050, Equity in Pretrial Health Coverage Act Monitor the following: COVID-19 Emergency program related issues H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Mental Health and Recovery Services; Integrated Health Services H.R.1368, Mental Health Justice Act H.R.953, Getting Americans Safely Back to Work Act of 2021, Local Health department issues Health equities H.R.2367, SOBER Homes Act, generally Foster care facility related issues

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 117-328, Consolidated Appropriations Act, FY2023, Fusion Center issues H.R.8256/S.4664, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2023, Monitor Public Safety programs generally; Monitor Criminal Justice issues generally; Fusion Center issues; Monitor Juvenile Vocational Training issues Medicaid Inmate Exclusion related issues, as follows: H.R.955/S.285, Medicaid Reentry Act of 2021 H.R.6636/S.2697, Due Process Continuity of Care Act S.3050, Equity in Pretrial Health Coverage Act Monitor the following: H.R.4505/S.3042, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2022, Public safety programs and integrating behavioral health and criminal justice services; Office of Justice programs related issues; and State Criminal Alien Assistance program Integrating public safety and homeless efforts H.R.1368, the Mental Health Justice Act Urban Area Security Initiatives State Homeland Security program High Intensity Drug Trafficking Areas program The Fight Fentanyl Act, Entirety Police reform generally

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support public health legislation including: Medicaid Reentry Act (H.R. 955, S. 285), Due Process Continuity of Care Act (H.R. 6636, S. 2697), Equity in Pretrial Health Coverage Act (S. 3050).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 432 - Mental Health Access Improvement Act H.R. 909 / S. 484 - The Moms Matter Act H.R. 1475/ S. 1795 - Pursuing Equity in Mental Health Act H.R. 3173 - Improving Seniors Timely Access to Care Act of 2021 H.R. 3541 / S. 1810 - Conrad State 30 and Physician Access Reauthorization Act H.R. 3753/ S. 1962 - Parity Implementation Assistance Act H.R. 4058 / S. 2061 - Telemental Health Care Access Act H.R. 4122 / S. 3658 - Resident Education Deferred Interest (REDI) Act H.R. 4217 / S. 2779 - TRIUMPH for New Moms Act H.R. 4770 - Evaluating Disparities and Outcomes of Telehealth (EDOT) Act of 2021 H.R. 5218 - Collaborate in an Orderly and Cohesive Manner Act H.R. 6000 - Cures 2.0 Act H.R. 6636 / S. 2697 - Due Process Continuity of Care Act H.R. 7073 / S. 3824 - Into the Light for Maternal Mental Health and Substance Use Disorders Act H.R. 7116 - 988 Implementation Act of 2022 H.R. 7232 - 988 and Parity Assistance Act of 2022 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022 H.R. 7857 - Minority Fellowship Program Reauthorization Act of 2022 H.R. 8180 - Undertaking Needed Investments in Therapy, Education, and De-Escalation (UNITED) Act of 2022 H.R. 8229 - Telemental Health Parity Act H.R. 8391 - CONNECT Act H.R. 8800 - Supporting Medicare Providers Act of 2022 H.R. 8830 / S. 4003 - Law Enforcement De-escalation Training Act H.R. 8878 - Intensive Outpatient Policy H.R. 8879 - Inpatient Psychiatric Facility Improvement Act H.R. 8881 - Mental Health Transparency Act H.R. 8884 - Medicare Opioid Use Disorder Outreach Act H.R. 8885 - Better Health Care Directories Act H.R. 8886 - Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act H.R. 8889 - Readable Insurance Coverage Enhancement (RICE) Act H.R. 8890 - Physician Wellness Program Act H.R. 8891 - No Surprises for Survivors Act H.R. 8892 - Access to Mental Health Services Act H.R. 8908 - Fighting Stimulant and other Substance Use Disorders Act H.R. 8910 - Behavioral Health Integration Awareness Act H.R. 9201 - Community Mental Wellness and Resilience Act H.R. 9499 - CCBHC Expansion Act of 2022 S. 2144 - PEERS Act of 2021 S. 2425 - Suicide Prevention Lifeline Improvement Act S. 4747 - Investing in Kids Mental Health Now Act S. 4965 - A bill to amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology. S.5041 - Training Psychiatrists for the Future Act S.5042 - More Behavioral Health Providers Act S.5043 - Expand the Behavioral Health Workforce Act S.5061 - Expand Qualified Psychologist Services Act S.5062 - Protect Our Physicians Act S.5272 - Increasing Mental Health Options of 2022 Senate Finance Kids Mental Health Draft Senate Finance Telehealth Draft Senate Finance Integrated Care Draft Senate Finance Workforce Draft Senate Finance Parity Draft

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

H.R. 8800, Supporting Medicare Providers Act of 2022 Medicare coverage policies and statutes affecting psychologists and psychology trainees practice and reimbursement Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058/ S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act HR 3173/S. 3018 Improving Seniors Access to Timely Care Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act of 2021 S. 5272 / H.R. 9577, Increasing Mental Health Options Act Draft bill re: Medicare reimbursement of services provided by advanced trainees Response to RFI re: Medicaid and behavioral health access Meeting with CMS staff re: digital therapeutics coding proposal

H.R. 8800, Supporting Medicare Providers Act of 2022 Medicare coverage policies and statutes affecting psychologists and psychology trainees practice and reimbursement Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058/ S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act HR 3173/S. 3018 Improving Seniors Access to Timely Care Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act of 2021 S. 5272 / H.R. 9577, Increasing Mental Health Options Act Draft bill re: Medicare reimbursement of services provided by advanced trainees Response to RFI re: Medicaid and behavioral health access Meeting with CMS staff re: digital therapeutics coding proposal

Excellence in Mental Health and Addiction Treatment Act (S. 2069/ H.R. 4323), all provisions related to expanding and extending the Certified Community Behavioral Health Clinic Medicaid demonstration program. Mental Health Access Improvement Act (S. 828/H.R. 432), all provisions related to allowing marriage and family therapists and mental health counselors to directly bill Medicare for their services. Medicaid Reentry Act (H.R. 955/S. 285), all provisions related to allowing Medicaid coverage for eligible incarcerated individuals to be re-established up to 30 days before their release from jail or prison. Promoting Effective and Empowering Recovery Services in Medicare (PEERS) Act of 2021 (H.R. 2767), all provisions related to allowing peer support specialists to participate in behavioral health integration services under Medicare. Permanency for Audio-Only Telehealth Act (H.R. 3447), all provisions related to expanding access to audio-only telehealth under Medicare. Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act (H.R. 1647/S. 340), all provisions related to coverage of certain telehealth services under Medicare. Excellence in Recovery Housing Act (H.R. 2376/S. 2901), all provisions related to the availability of high-quality recovery housing for individuals with substance use disorders. Due Process Continuity of Care Act (H.R. 6636/S. 2697), all provisions related to the removal of the Medicaid coverage exclusion for inmates in custody pending disposition of charges. Supporting Medicare Providers Act of 2022 (H.R. 8800), all provisions related to the extension of certain increases in payments for physicians services under the Medicare program through 2023.

Client expense: $150,000 · Firm income: Not reported

H.R. 8800, Supporting Medicare Providers Act of 2022 Medicare coverage policies and statutes affecting psychologists and psychology trainees practice and reimbursement Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058/ S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act HR 3173/S. 3018 Improving Seniors Access to Timely Care Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act of 2021 Draft bill re: Medicare reimbursement of services provided by advanced trainees

Client expense: $520,000 · Firm income: Not reported

Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058: Telemental Health Care Access Act S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act HR 3173/S. 3018 Improving Seniors Access to Timely Care Act Draft bill re: Medicare reimbursement of services provided by advanced trainees

Client expense: $260,000 · Firm income: Not reported

Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058: Telemental Health Care Access Act S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act HR 3173/S. 3018 Improving Seniors Access to Timely Care Act Draft bill re: Medicare reimbursement of services provided by advanced trainees

Client expense: $260,000 · Firm income: Not reported

Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058: Telemental Health Care Access Act S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act HR 3173/S. 3018 Improving Seniors Access to Timely Care Act Draft bill re: Medicare reimbursement of services provided by advanced trainees

Client expense: $260,000 · Firm income: Not reported

Excellence in Mental Health and Addiction Treatment Act (S. 2069/ H.R. 4323), all provisions related to expanding and extending the Certified Community Behavioral Health Clinic Medicaid demonstration program. Mental Health Access Improvement Act (S. 828/H.R. 432), all provisions related to allowing marriage and family therapists and mental health counselors to directly bill Medicare for their services. Medicaid Reentry Act (H.R. 955/S. 285), all provisions related to allowing Medicaid coverage for eligible incarcerated individuals to be re-established up to 30 days before their release from jail or prison. Promoting Effective and Empowering Recovery Services in Medicare (PEERS) Act of 2021 (H.R. 2767), all provisions related to allowing peer support specialists to participate in behavioral health integration services under Medicare. Permanency for Audio-Only Telehealth Act (H.R. 3447), all provisions related to expanding access to audio-only telehealth under Medicare. Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act (H.R. 1647/S. 340), all provisions related to coverage of certain telehealth services under Medicare. Excellence in Recovery Housing Act (H.R. 2376/S. 2901), all provisions related to the availability of high-quality recovery housing for individuals with substance use disorders. Due Process Continuity of Care Act (H.R. 6636/S. 2697), all provisions related to the removal of the Medicaid coverage exclusion for inmates in custody pending disposition of charges.

Client expense: $140,000 · Firm income: Not reported

Excellence in Mental Health and Addiction Treatment Act (S. 2069/ H.R. 4323), all provisions related to expanding and extending the Certified Community Behavioral Health Clinic Medicaid demonstration program. Mental Health Access Improvement Act (S. 828/H.R. 432), all provisions related to allowing marriage and family therapists and mental health counselors to directly bill Medicare for their services. Medicaid Reentry Act (H.R. 955/S. 285), all provisions related to allowing Medicaid coverage for eligible incarcerated individuals to be re-established up to 30 days before their release from jail or prison. Promoting Effective and Empowering Recovery Services in Medicare (PEERS) Act of 2021 (H.R. 2767), all provisions related to allowing peer support specialists to participate in behavioral health integration services under Medicare. Permanency for Audio-Only Telehealth Act (H.R. 3447), all provisions related to expanding access to audio-only telehealth under Medicare. Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act (H.R. 1647/S. 340), all provisions related to coverage of certain telehealth services under Medicare. Excellence in Recovery Housing Act (H.R. 2376/S. 2901), all provisions related to the availability of high-quality recovery housing for individuals with substance use disorders. Due Process Continuity of Care Act (H.R. 6636/S. 2697), all provisions related to the removal of the Medicaid coverage exclusion for inmates in custody pending disposition of charges.

Client expense: $140,000 · Firm income: Not reported

Draft Legislation - IMD Medicaid (Napolitano) S. 586: NO PAIN Act H.R. 1551/S 584: Nutrition Counseling Aiding Recover for Eating Disorders Act H.R. 3450/S. 1727: Medicaid Bump Act H.R. 3447: Permanency for Audio Only Telehealth Act H.R. 4058: Telemental Health Care Access Act S. 2061: Telemental Health Care Access Act S. 2069: Excellence in Mental Health and Addiction Treatment Act H.R. 1738/S. 646: Stabilize Medicaid and CHIP Coverage Act S.285: Medicaid Reentry Act S.340: TREATS Act H.R. 1577/S. 596: Treat and Reduce Obesity Act H.R. 314: Medicare Sequester COVID Moratorium Act H.R 1868: To prevent across the board direct spending cuts S. 1512/H.R. 2903: CONNECT for Health Act H.R. 4480: Telehealth Coverage and Payment Parity Act S. 1798/H.R. 1398: TIKES Act Letter to CMS re: TN Medicaid proposed amendment (Coalition letter) H.R. 5674 / S. 3061: Medicare Mental Health Inpatient Equity Act H.R. 2503 Social Determinants Accelerator Act of 2021 Medicaid/Medicare/Private Insurance provisions in the Build Back Better Act S. 610, Public Law 117-71: Protecting Medicare and American Farmers from Sequester Cuts Act H.R. 4406 Supporting Medicaid in the U.S. Territories Act H.R. 341 Ensuring Telemental Health Expansion Act of 2021 H.R. 6698 Stop Unfair Medicaid Recoveries Act H.R. 6636 / S. 2697 Due Process Continuity of Care Act

Client expense: $226,000 · Firm income: Not reported